Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

In our ongoing project to catch up with last year’s TR35, we sat down with Shiladitya Sengupta, now an assistant professor in the Harvard-MIT Division of Health Sciences and Technology. He talked with us about how the “nanocell” cancer treatment technology that initially drew him to our attention fits in with his philosophy of using technology to solve medical problems for everyone–not just the elite. Sengupta’s passion for applying basic science to the creation of medicines that patients can actually use is unmistakable.

0 comments about this story. Start the discussion »

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me